Literature DB >> 8610188

The need for epidemic intelligence.

A B Bloch1, I M Onorato, W W Ihle, J L Hadler, C H Hayden, D E Snider.   

Abstract

The past decade has witnessed an unprecedented upturn in tuberculosis morbidity and outbreaks of difficult- to-treat and highly lethal multidrug-resistant tuberculosis. In the early 1990s, a national consensus developed among public health officials to define more comprehensively the problem, and in January 1993, expanded tuberculosis surveillance was implemented nationwide. Carefully selected epidemiologic and case management variables were added to the Report of Verified Case of Tuberculosis form. Information is collected on the health status and treatment of patients, including human immunodeficiency virus status, drug susceptibility test results, and the initial drug regimen. Completion of therapy and use of directly observed therapy are also monitored. The new surveillance system allows a comparison of the quality of care of patients in the public and private sectors. Additional epidemiologic variables include membership in high-risk groups (the homeless, residents of correctional or long-term care facilities, migrant workers, health care workers, and correctional employees) and substance abuse (injecting drug use, non-injecting drug use, and excess alcohol use). The additional information derived from expanded tuberculosis surveillance is crucial to optimal patient management, policy development, resource allocation, as well as program planning, implementation, and evaluation at Federal, State, and local levels.

Entities:  

Mesh:

Year:  1996        PMID: 8610188      PMCID: PMC1381737     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  30 in total

Review 1.  Tuberculosis in the United States.

Authors:  H L Rieder; G M Cauthen; G D Kelly; A B Bloch; D E Snider
Journal:  JAMA       Date:  1989-07-21       Impact factor: 56.272

2.  Association of tuberculosis with alcoholism.

Authors:  A O Feingold
Journal:  South Med J       Date:  1976-10       Impact factor: 0.954

Review 3.  Public health surveillance in the United States.

Authors:  S B Thacker; R L Berkelman
Journal:  Epidemiol Rev       Date:  1988       Impact factor: 6.222

4.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.

Authors:  P A Selwyn; D Hartel; V A Lewis; E E Schoenbaum; S H Vermund; R S Klein; A T Walker; G H Friedland
Journal:  N Engl J Med       Date:  1989-03-02       Impact factor: 91.245

5.  Predictors of short-term prognosis in patients with pulmonary tuberculosis.

Authors:  P F Barnes; J M Leedom; L S Chan; S F Wong; J Shah; L A Vachon; G D Overturf; R L Modlin
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

Review 6.  Treatment of multidrug-resistant tuberculosis.

Authors:  M D Iseman
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

7.  Pulmonary tuberculosis in elderly men.

Authors:  S Alvarez; C Shell; S L Berk
Journal:  Am J Med       Date:  1987-03-23       Impact factor: 4.965

Review 8.  The epidemiology of multidrug-resistant tuberculosis in the United States.

Authors:  J H Kent
Journal:  Med Clin North Am       Date:  1993-11       Impact factor: 5.456

9.  Tuberculosis screening in alcoholics and drug addicts.

Authors:  L N Friedman; G M Sullivan; R P Bevilaqua; R Loscos
Journal:  Am Rev Respir Dis       Date:  1987-11

10.  Drug dependence, a possible new risk factor for tuberculosis disease.

Authors:  L B Reichman; C P Felton; J R Edsall
Journal:  Arch Intern Med       Date:  1979-03
View more
  10 in total

1.  Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary?

Authors:  R Bayer; C Stayton; M Desvarieux; C Healton; S Landesman; W Y Tsai
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

2.  Commentary on TB testing of inmates.

Authors:  R B Greifinger
Journal:  Public Health Rep       Date:  1996 Jul-Aug       Impact factor: 2.792

3.  Molecular fingerprinting of Mycobacterium tuberculosis and risk factors for tuberculosis transmission in Paris, France, and surrounding area.

Authors:  M C Gutiérrez; V Vincent; D Aubert; J Bizet; O Gaillot; L Lebrun; C Le Pendeven; M P Le Pennec; D Mathieu; C Offredo; B Pangon; C Pierre-Audigier
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Impact of social interactions in the community on the transmission of tuberculosis in a high incidence area.

Authors:  C N Classen; R Warren; M Richardson; J H Hauman; R P Gie; J H Ellis; P D van Helden; N Beyers
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

5.  Cross-matching TB and AIDS registries: TB patients with HIV co-infection, United States, 1993-1994.

Authors:  M Moore; E McCray; I M Onorato
Journal:  Public Health Rep       Date:  1999 May-Jun       Impact factor: 2.792

6.  The fall after the rise: Tuberculosis in the United States, 1991 through 1994.

Authors:  M T McKenna; E McCray; J L Jones; I M Onorato; K G Castro
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

7.  Completeness and timeliness of tuberculosis notification in Taiwan.

Authors:  Hsiu-Yun Lo; Shiang-Lin Yang; Pesus Chou; Jen-Hsiang Chuang; Chen-Yuan Chiang
Journal:  BMC Public Health       Date:  2011-12-12       Impact factor: 3.295

8.  Assessing the validity of tuberculosis surveillance data in California.

Authors:  Joan E Sprinson; Elizabeth S Lawton; Travis C Porco; Jennifer M Flood; Janice L Westenhouse
Journal:  BMC Public Health       Date:  2006-08-25       Impact factor: 3.295

Review 9.  Responding to pandemics and other disease outbreaks in homeless populations: A review of the literature and content analysis.

Authors:  Jordan Babando; Danika A Quesnel; Kyler Woodmass; Arielle Lomness; John R Graham
Journal:  Health Soc Care Community       Date:  2021-04-06

Review 10.  An evaluation of completeness of tuberculosis notification in the United Kingdom.

Authors:  Jayshree Pillaye; Aileen Clarke
Journal:  BMC Public Health       Date:  2003-10-06       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.